Puma Biotechnology, Inc. | LinkedIn
Puma Biotechnology (PBYI) - 5 Price Charts 2012-2023 (History)
Puma Biotechnology Announces Exclusive License Agreement with Takeda for the Development and Commercialization of Alisertib, an Investigational Aurora Kinase A Inhibitor | Business Wire
Puma Biotechnology Reports Results of PB272 (neratinib) in P-III NALA Trial for Patients with 2L+ HER2+ Metastatic Breast Cancer #ASCO2019
Puma Biotechnology
Exhibitor Puma Biotechnology 11-6 - Scripps CME Connection
Why Puma Biotechnology (PBYI) Stock Is Surging Today - TheStreet
Puma Biotechnology Secures $125 Million Note Purchase by Athyrium Capital | citybiz
Why Puma Biotechnology Is Soaring Today | The Motley Fool
Puma Biotechnology Surging
Puma Biotechnology (PBYI) Presents At Barclays Global Healthcare Virtual Conference (NASDAQ:PBYI) | Seeking Alpha
Former Puma Biotech executive gets U.S. prison term for insider trading | Reuters.com
Puma Biotechnology Announces Exclusive License Agreement with Takeda for the Development and Commercialization of Alisertib, an Investigational Aurora Kinase A Inhibitor | Business Wire
Puma Biotechnology, Inc. (PBYI) Company Information - Simply Wall St
PUMA BIOTECHNOLOGY, INC. : PBYI Stock Price | US74587V1070 | MarketScreener
Puma Biotechnology
Puma Biotechnology
Millennium Management Llc discloses stake in PBYI / Puma Biotechnology Inc
Puma Biotechnology
Puma Biotechnology, Inc. 2018 Q3 - Results - Earnings Call Slides (NASDAQ:PBYI) | Seeking Alpha
Former Puma Biotechnology exec is accused of making $1.2 million from insider trading - Los Angeles Times
Puma Biotechnology (PBYI) Stock Climbs On Orphan Drug Designation | Alpha Stock News
